75 Participants Needed

Hypertonic Saline for Brain Disorders

JR
CR
Overseen ByCatherine Roth, MPH
Age: < 65
Sex: Any
Trial Phase: Phase 2 & 3
Sponsor: Joseph D. Tobias
Stay on Your Current MedsYou can continue your current medications while participating
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This is a prospective, randomized study in patients greater than or equal to 10 years of age scheduled for an posterior spinal fusion that requires invasive monitoring of arterial blood pressure. Subjects will be randomized to receive either standard of care Normosol-R or buffered 2% hypertonic saline for intraoperative fluid resuscitation.The primary objective of this study is to compare intraoperative changes in acid-base status and electrolytes based on the type of fluid administered intraoperatively.The secondary objective is to compare the volume of fluid required and use of adjunctive volume resuscitation with 5% albumin for intraoperative resuscitation when using standard Normosol-R or a novel buffered 2% saline solution.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Is hypertonic saline safe for use in humans?

Research shows that hypertonic saline, including 2%, 3%, and 23.4% solutions, is generally safe for treating brain-related conditions like cerebral edema and traumatic brain injury. It has been safely used in both emergency and tactical settings, although more studies are needed to confirm its safety in all situations.12345

How is Buffered 2% Hypertonic Saline different from other treatments for brain disorders?

Buffered 2% Hypertonic Saline is unique because it is used as an osmotherapy to reduce brain swelling, particularly in cases of traumatic brain injury. It has advantages over other treatments like mannitol, as it can improve blood flow in the brain and reduce pressure inside the skull, although more research is needed to confirm its routine use.56789

What data supports the effectiveness of the drug Buffered 2% Hypertonic Saline for brain disorders?

Research shows that hypertonic saline solutions, like the 2% version, can help reduce brain swelling and improve outcomes in brain injuries. Studies suggest they are effective in managing traumatic brain injuries by decreasing brain size and improving blood flow.457810

Are You a Good Fit for This Trial?

This trial is for young patients aged 8-21 who are scheduled for brain surgery and need close blood pressure monitoring. They must require two IV infusions and an arterial cannula during surgery. Those not needing these or unable to have an arterial cannula placed cannot join.

Inclusion Criteria

I am scheduled for brain surgery.
I need two IV lines and an arterial line placed.

Exclusion Criteria

Two peripheral intravenous cannulas are not required
An invasive arterial cannula cannot be placed
Arterial cannula is not indicated for the surgical procedure

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intraoperative Treatment

Participants receive either 0.9% normal saline or buffered 2% hypertonic saline for fluid resuscitation during surgery

4-6 hours
Single visit (in-person, during surgery)

Follow-up

Participants are monitored for safety and effectiveness after surgery

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Buffered 2% Hypertonic Saline
Trial Overview The study compares the effects of two saline solutions used during brain surgery: standard 0.9% saline versus a buffered 2% hypertonic saline. It looks at how each solution affects acid-base balance, electrolytes, and the amount of fluid needed.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Hypertonic salineExperimental Treatment1 Intervention
Group II: Normosol-RActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Joseph D. Tobias

Lead Sponsor

Trials
24
Recruited
4,000+

Citations

Variable change in renal function by hypertonic saline. [2021]
Effect of continuous infusion of hypertonic saline solution on survival of patients with brain injury: a systematic review and meta-analysis. [2023]
23.4% Hypertonic Saline: A Tactical Option for the Management of Severe Traumatic Brain Injury With Impending or Ongoing Herniation. [2022]
The role of hypertonic saline in neurotrauma. [2013]
Hypertonic saline solutions in brain injury. [2019]
Early continuous hypertonic saline infusion in patients with severe cerebrovascular disease. [2022]
Safety of peripheral 3% hypertonic saline bolus administration for neurologic emergency. [2023]
Management of hyponatremic seizures in children with hypertonic saline: a safe and effective strategy. [2019]
Hypertonic saline and its effect on intracranial pressure, cerebral perfusion pressure, and brain tissue oxygen. [2013]
10.United Statespubmed.ncbi.nlm.nih.gov
23.4% Hypertonic Saline and Intracranial Pressure in Severe Traumatic Brain Injury Among Children: A 10-Year Retrospective Analysis. [2020]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security